相关实验视频

Updated: Jul 24, 2025

Author Spotlight: Enhancing Coronary Artery Revascularization

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

冠状动脉旁路移植后MAGGIC评分的预测能力:一项比较研究

Sevgi Ozcan¹, Esra Dönmez¹, Murat Ziyrek¹

¹Department of Cardiology, Bağcılar Training and Research Hospital, Bağcılar, İstanbul, Turkey.

Brazilian journal of cardiovascular surgery

|July 4, 2023

概括

慢性心力衰竭 (MAGGIC) 的全球基准分析小组得分准确地预测了冠状动脉旁路移植 (CABG) 后的短期和长期死亡率. 这一分数表明,与EuroSCORE II和STS相比,CABG患者的预后能力更强.

科学领域:

心脏病学心脏病学
心脏外科手术心脏外科手术
风险分层是风险的分层.

背景情况:

像EuroSCORE II和STS这样的既定风险评分用于预测冠状动脉绕道移植 (CABG) 后的短期死亡率.
全球慢性心力衰竭 (MAGGIC) 评分的元分析,最初是针对心力衰竭,已经显示出预测心脏门手术后死亡率的潜力.

研究的目的:

评估MAGGIC得分能够预测CABG患者的短期和长期死亡率的能力.
将MAGGIC评分的预测能力与已建立的EuroSCORE II和STS评分系统进行CABG结果的比较.

主要方法:

一项回顾性研究包括了为慢性冠状动脉综合征接受CABG的患者.
收集后续数据以评估MAGGIC评分的预测能力.
将MAGGIC的预测性能与STS和EuroSCORE-II进行了30天,一年和10年死亡率的比较.

主要成果:

这三种评分 (MAGGIC,STS,EuroSCORE-II) 都显示出良好的预测能力.
MAGGIC得分显示出30天 (AUC:0.903),一年 (AUC:0.931) 和10年 (AUC:0.923) 死亡率的优异预测能力.
MAGGIC被确定为死亡率的独立预测因子,具有统计学上显著的长期关联.

结论:

MAGGIC评分系统为CABG患者的早期和长期死亡率提供了良好的预测准确度.
与EuroSCORE II和STS相比,MAGGIC使用更少的变量提供了更好的预测能力.
MAGGIC是进行CABG的患者风险分层的一个有价值的工具.

关键词:

曲线下的面积曲线下的面积冠状动脉绕道 (bypass) 是一种冠状动脉绕道.这是心脏衰竭.预测预测预测预测结果的可复制性结果的可复制性风险评估风险评估

更多相关视频

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

相关概念视频

Coronary Artery Disease V: Interprofessional Care

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

Acute Coronary Syndrome III: Diagnostic Studies

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...